• Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

iShares Nasdaq Biotechnology ETF

+ Add to Watchlist

IBB:US

288.7700 USD 5.1500 1.82%

As of 20:10:00 ET on 10/24/2014.

Snapshot for iShares Nasdaq Biotechnology ETF (IBB)

Open: 283.8200 High - Low: 288.8950 - 282.7900 Primary Exchange: NASDAQ GM
Volume: 1,422,487 52-Week Range: 197.4400 - 288.8950 Beta vs XNBI: 0.9995

ETF Chart for IBB

No chart data available.
  • IBB:US 288.7700
  • 1D
  • 1M
  • 1Y
283.6200
Interactive IBB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for IBB

iShares Nasdaq Biotechnology ETF is an exchange-traded fund incorporated in the USA. The Fund's objective seeks investment results that correspond to the performance of the Nasdaq Biotechnology Index. The Fund will concentrate its investments in companies primarily engaged in using biomedical research for the discovery or development of new treatments or cures for human disease.

Inception Date: 2001-02-09 Telephone: 1-415-670-2000
Managers: GREG SAVAGE
Web Site: www.ishares.com

Fundamentals for IBB

NAV (on 2014-10-24) 288.6600
Assets (M) (on 2014-10-24) 6,191.8300
Shares out (M) 21.45
Market Cap (M) 6,194.12
% Premium 0.04
Average 52-Week % Premium 0.0019
Fund Leveraged N

Dividends for IBB

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net -
Dividend Yield (ttm) 0.15%

Performance for IBB

1-Month +3.39% 1-Year +36.90%
3-Month +13.07% 3-Year +43.23%
Year To Date +27.40% 5-Year +30.67%
Expense Ratio 0.48

Top Fund Holdings for IBB

Filing Date: 10/23/2014
Name Position Value % of Total
Celgene Corp 4,971,552 499,143,821 8.361%
Amgen Inc 3,389,259 499,068,388 8.359%
Gilead Sciences Inc 4,391,110 470,639,170 7.883%
Regeneron Pharmaceuticals Inc 1,171,738 461,617,902 7.732%
Biogen Idec Inc 1,377,096 435,244,962 7.290%
Vertex Pharmaceuticals Inc 2,524,323 272,854,073 4.570%
Alexion Pharmaceuticals Inc 1,395,255 259,405,810 4.345%
Illumina Inc 1,316,912 244,734,926 4.099%
Mylan Inc/PA 4,834,814 243,819,670 4.084%
BioMarin Pharmaceutical Inc 1,901,562 142,636,166 2.389%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil